News
The $50 billion target, which AstraZeneca plans to meet by 2030, includes new manufacturing projects in Virginia and ...
AstraZeneca ( AZN) said it is investing $50 billion in U.S. manufacturing by 2030, following the lead of big pharma peers ...
The company said the Virginia facility "would be AstraZeneca’s largest single manufacturing investment in the world." The ...
Virginia facility investment will be AstraZeneca’s largest yet. Maryland, Massachusetts, California, Indiana, Texas projects ...
AstraZeneca announces $50B US investment by 2030, creating thousands of jobs and building its largest drug manufacturing facility in Virginia.
AstraZeneca today announces $50 billion of investment in the United States by 2030, building on America’s global leadership in medicines manufacturing and R&D. This investment is expected to create ...
AstraZeneca (LSE:AZN) TAGRISSO Shows Clinically Meaningful Survival Improvement In Lung Cancer Study
AstraZeneca (LSE:AZN) recently announced positive developments regarding TAGRISSO®'s survival benefits in treating non-small ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results